Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Phase II Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes (rAd26-rAd5, ChAdOx1 nCoV-19 and BBIBP-CorV).

NCT04962906 is registered in ClinicalTrials.gov with Ministerio de Salud de Ciudad Autónoma de Buenos Aires as lead sponsor.

NCT NCT04962906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04962906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Phase II Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes (rAd26-rAd5, ChAdOx1 nCoV-19 and BBIBP-CorV).
Lead sponsor
Ministerio de Salud de Ciudad Autónoma de Buenos Aires
Phase
Phase 2
Overall status
Completed
Start date
July 5, 2021
Completion date
August 15, 2021
Enrollment
192 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 vaccines